Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Fiscal Period | Report Date | EPS | Revenue |
|---|---|---|---|
| Quarter 3, 2024 | 2024-11-12 | -0.10 +0.02 | 1.038 M +915.14 K |
| Quarter 2, 2024 | 2024-08-12 | -0.10 +0.04 | 90 K -36.5 K |
| Quarter 1, 2024 | 2024-05-09 | -0.17 -0.03 | 230 K -451.25 K |
| Quarter 4, 2023 | 2024-03-12 | -0.080 -0.01 | 6.345 M +2.105 M |
| Quarter 3, 2023 | 2023-11-13 | -0.15 +0.00 | 859 K +726.8 K |
| Quarter 2, 2023 | 2023-08-14 | -0.15 -0.01 | 1.018 M +950.25 K |
| Quarter 1, 2023 | 2023-05-12 | -0.15 -0.01 | 4 K -56 K |
The chart above depicts the trend in analyst earnings per share (EPS) forecasts for Clearside Biomedical Inc for the upcoming quarter. Analysts have increased this quarter's expectations by 17.3% for EPS from -0.13 per share to -0.10 per share over the last 12 months. The company is expected to report earnings for Q4, 2024, on March 27, 2025.